Clinical Trial Update: Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 single-dose pharmacokinetic study of controlled-release paroxetine tablets in healthy Japanese male subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED